{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:19Z","timestamp":1786988119300,"version":"build-2736575974"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007254","name":"Creighton University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejpb.2021.02.003","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T08:46:45Z","timestamp":1613378805000},"page":"66-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Polyphenols against infectious diseases: Controlled release nano-formulations"],"prefix":"10.1016","volume":"161","author":[{"given":"Namratha","family":"Turuvekere Vittala Murthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhuti","family":"Agrahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2021.02.003_b0005","unstructured":"WHO | Birth in a time of antibiotic-resistant bacteria, WHO, 2016."},{"key":"10.1016\/j.ejpb.2021.02.003_b0010","unstructured":"Jim O\u2019Neil, Review on Antimicrobial Resistance.Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Review on Antimicrobial Resistance, 2014."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.003_b0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/003335491212700103","article-title":"A review of antibiotic use in food animals: perspective, policy, and potential","volume":"127","author":"Landers","year":"2012","journal-title":"Public Health Rep."},{"key":"10.1016\/j.ejpb.2021.02.003_b0020","unstructured":"Tackling drug-resistant infections globally: final report and recommendations the review on antimicrobial resistance CHAIRED BY JIM O\u2019NEILL (2016)."},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.003_b0025","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1473-3099(11)70005-6","article-title":"Guidelines for hospital-acquired pneumonia and health-care-associated pneumonia: a vulnerability, a pitfall, and a fatal flaw","volume":"11","author":"Yu","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejpb.2021.02.003_b0030","unstructured":"C.D.C. Newsroom, Untreatable: Report by CDC details today\u2019s drug-resistant health threats, 2014."},{"issue":"4","key":"10.1016\/j.ejpb.2021.02.003_b0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2165\/00003495-200262040-00001","article-title":"Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium","volume":"62","author":"Sefton","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.ejpb.2021.02.003_b0040","unstructured":"Niaid. NIAID Antimicrobial Resistance Program: Current Status and Future Directions 2014, 2014."},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.003_b0045","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2672.2003.02026.x","article-title":"Novel antiviral agents: a medicinal plant perspective","volume":"95","author":"Jassim","year":"2003","journal-title":"J. Appl. Microbiol."},{"issue":"6","key":"10.1016\/j.ejpb.2021.02.003_b0050","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1517\/17460441.2015.1048219","article-title":"Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?","volume":"10","author":"Penchovsky","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejpb.2021.02.003_b0055","unstructured":"Antibiotic Resistant Gonorrhea - STD information from CDC. (n.d.)., 2020, from https:\/\/www.cdc.gov\/std\/gonorrhea\/arg\/default.htm."},{"issue":"4","key":"10.1016\/j.ejpb.2021.02.003_b0060","first-page":"203","article-title":"Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Rev. Microbiol."},{"key":"10.1016\/j.ejpb.2021.02.003_b0065","unstructured":"Healthcare Settings | MRSA | CDC. (n.d.). 2019, from https:\/\/www.cdc.gov\/mrsa\/healthcare\/index.html."},{"key":"10.1016\/j.ejpb.2021.02.003_b0070","unstructured":"Acinetobacter in Healthcare Settings | HAI | CDC. (n.d.). Retrieved August 29, 2020, from https:\/\/www.cdc.gov\/hai\/organisms\/acinetobacter.html."},{"key":"10.1016\/j.ejpb.2021.02.003_b0075","unstructured":"New report calls for urgent action to avert antimicrobial resistance crisis. (n.d.).2019, from https:\/\/www.who.int\/news-room\/detail\/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis."},{"key":"10.1016\/j.ejpb.2021.02.003_b0080","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","article-title":"Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis","volume":"45","author":"Unissa","year":"2016","journal-title":"Infection, Genet. Evol."},{"issue":"11","key":"10.1016\/j.ejpb.2021.02.003_b0085","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4155\/fmc.11.95","article-title":"Drug repositioning in the treatment of malaria and TB","volume":"3","author":"Nzila","year":"2011","journal-title":"Future Med. Chem."},{"issue":"6","key":"10.1016\/j.ejpb.2021.02.003_b0090","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1007\/s00044-012-0268-7","article-title":"Screening of flavonoids for antitubercular activity and their structure-activity relationships","volume":"22","author":"Yadav","year":"2013","journal-title":"Med. Chem. Res."},{"issue":"4","key":"10.1016\/j.ejpb.2021.02.003_b0095","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1586\/14787210.4.4.601","article-title":"Treatment options for multidrug-resistant bacteria","volume":"4","author":"Giamarellou","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ejpb.2021.02.003_b0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fmed.2019.00074","article-title":"Treatment of infections due to MDR gram-negative bacteria","volume":"6","author":"Bassetti","year":"2019","journal-title":"Front. Med."},{"key":"10.1016\/j.ejpb.2021.02.003_b0105","first-page":"6055","article-title":"Natural product-based nanomedicine: recent advances and issues","volume":"10","author":"Watkins","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2021.02.003_b0110","doi-asserted-by":"crossref","unstructured":"M. Ayaz, F. Ullah, A. Sadiq, F. Ullah, M. Ovais, J. Ahmed, H.P. Devkota, Synergistic interactions of phytochemicals with antimicrobial agents: potential strategy to counteract drug resistance, in: Chemico-Biological Interactions, vol. 308. Elsevier Ireland Ltd., 2019, pp. 294\u2013303 https:\/\/doi.org\/10.1016\/j.cbi.2019.05.050.","DOI":"10.1016\/j.cbi.2019.05.050"},{"issue":"8","key":"10.1016\/j.ejpb.2021.02.003_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s42452-020-3110-8","article-title":"Nanopolyphenols: a review of their encapsulation and anti-diabetic effects","volume":"2","author":"Rambaran","year":"2020","journal-title":"SN Appl. Sci."},{"key":"10.1016\/j.ejpb.2021.02.003_b0120","doi-asserted-by":"crossref","unstructured":"R. Barbieri, E. Coppo, A. Marchese, M. Daglia, E. Sobarzo-S\u00e1nchez, S.F. Nabavi, S.M. Nabavi, Phytochemicals for human disease: an update on plant-derived compounds antibacterial activity, in :Microbiological Research, vol. 196. Elsevier GmbH, 2017, pp. 44\u201368. https:\/\/doi.org\/10.1016\/j.micres.2016.12.003.","DOI":"10.1016\/j.micres.2016.12.003"},{"key":"10.1016\/j.ejpb.2021.02.003_b0125","first-page":"29","article-title":"Polyphenols and their formulations: different strategies to overcome the drawbacks associated with their poor stability and bioavailability","volume":"1","author":"Parisi","year":"2013","journal-title":"Polyphenols Human Health Dis."},{"issue":"10","key":"10.1016\/j.ejpb.2021.02.003_b0130","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3390\/ijerph15102321","article-title":"Phenolic compounds diminish antibiotic resistance of staphylococcus aureus clinical strains","volume":"15","author":"Miklasi\u0144ska-Majdanik","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.003_b0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijantimicag.2011.02.014","article-title":"Recent advances in understanding the antibacterial properties of flavonoids","volume":"38","author":"Cushnie","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejpb.2021.02.003_b0140","doi-asserted-by":"crossref","unstructured":"S. Ben-Shabat, L. Yarmolinsky, D. Porat, A. Dahan, Antiviral effect of phytochemicals from medicinal plants: applications and drug delivery strategies, in :Drug Delivery and Translational Research, vol. 10(2). Springer, 2019, pp. 354\u2013367. https:\/\/doi.org\/10.1007\/s13346-019-00691-6.","DOI":"10.1007\/s13346-019-00691-6"},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.003_b0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ddtec.2014.02.001","article-title":"General principles of antibiotic resistance in bacteria","volume":"11","author":"Martinez","year":"2014","journal-title":"Drug Discov. Today: Technol."},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.003_b0150","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol."},{"issue":"7","key":"10.1016\/j.ejpb.2021.02.003_b0155","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/AAC.45.7.1964-1971.2001","article-title":"Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay","volume":"45","author":"Okamoto","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.ejpb.2021.02.003_b0160","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.addr.2005.04.002","article-title":"Bacterial resistance to antibiotics: enzymatic degradation and modification","volume":"57","author":"Wright","year":"2005","journal-title":"Adv. Drug Delivery Rev."},{"issue":"s1","key":"10.1016\/j.ejpb.2021.02.003_b0165","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1046\/j.1365-2672.92.5s1.8.x","article-title":"Mechanisms of bacterial biocide and antibiotic resistance","volume":"92","author":"Poole","year":"2002","journal-title":"J. Appl. Microbiol."},{"issue":"10","key":"10.1016\/j.ejpb.2021.02.003_b0170","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.addr.2005.04.004","article-title":"Bacterial resistance to antibiotics: active efflux and reduced uptake","volume":"57","author":"Kumar","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.ejpb.2021.02.003_b0175","first-page":"25","article-title":"Antibiotics and bacterial resistance in the 21st century","volume":"6","author":"Fair","year":"2014","journal-title":"Perspectives Med. Chem."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.003_b0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13756-019-0559-6","article-title":"Review on plant antimicrobials: a mechanistic viewpoint","volume":"8","author":"Khameneh","year":"2019","journal-title":"Antimicrob. Resistance Infection Control"},{"issue":"6","key":"10.1016\/j.ejpb.2021.02.003_b0185","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1128\/AAC.48.6.1968-1973.2004","article-title":"Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells","volume":"48","author":"Roccaro","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2021.02.003_b0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.compbiolchem.2015.09.006","article-title":"Identification of chebulinic acid as potent natural inhibitor of M. tuberculosis DNA gyrase and molecular insights into its binding mode of action","volume":"59","author":"Patel","year":"2015","journal-title":"Comput. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.003_b0195","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0006-291X(03)01006-4","article-title":"Characterization of quercetin binding site on DNA gyrase","volume":"306","author":"Plaper","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.003_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/nu8020090","article-title":"Myricetin: A dietary molecule with diverse biological activities","volume":"8","author":"Semwal","year":"2016","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.ejpb.2021.02.003_b0205","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1002\/bit.25686","article-title":"Antimicrobial mechanism of resveratrol-trans-dihydrodimer produced from peroxidase-catalyzed oxidation of resveratrol","volume":"112","author":"Mora-Pale","year":"2015","journal-title":"Biotechnol. Bioeng."},{"issue":"4","key":"10.1016\/j.ejpb.2021.02.003_b0210","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1128\/AEM.68.4.1561-1568.2002","article-title":"The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus","volume":"68","author":"Ultee","year":"2002","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ejpb.2021.02.003_b0215","unstructured":"alpha-Mangostin | C24H26O6 - PubChem. (n.d.). Retrieved July 27, 2020, from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/alpha-Mangostin."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.003_b0220","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.bbamem.2012.09.004","article-title":"Rapid bactericidal action of alpha-mangostin against MRSA as an outcome of membrane targeting","volume":"1828","author":"Koh","year":"2013","journal-title":"Biochim. Biophys. Acta \u2013 Biomembr."},{"issue":"1\u20133","key":"10.1016\/j.ejpb.2021.02.003_b0225","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jep.2005.04.014","article-title":"Detection of galangin-induced cytoplasmic membrane damage in Staphylococcus aureus by measuring potassium loss","volume":"101","author":"Cushnie","year":"2005","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.003_b0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0031-9422(97)01105-9","article-title":"Mode of antibacterial action of retrochalcones from Glycyrrhiza inflata","volume":"48","author":"Haraguchi","year":"1998","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejpb.2021.02.003_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.126973","article-title":"Stability and release performance of curcumin-loaded liposomes with varying content of hydrogenated phospholipids","volume":"326","author":"Tai","year":"2020","journal-title":"Food Chem."},{"issue":"31","key":"10.1016\/j.ejpb.2021.02.003_b0240","doi-asserted-by":"crossref","first-page":"24055","DOI":"10.1074\/jbc.M110.114793","article-title":"Insertion of epicatechin gallate into the cytoplasmic membrane of methicillin-resistant Staphylococcus aureus disrupts penicillin-binding protein (PBP) 2a-mediated \u03b2-lactam resistance by delocalizing PBP2","volume":"285","author":"Bernal","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.003_b0245","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3390\/ijms14011802","article-title":"The combination of catechin and epicatechin gallate from fructus crataegi potentiates \u03b2-lactam antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo","volume":"14","author":"Qin","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2021.02.003_b0250","doi-asserted-by":"crossref","unstructured":"W.-H. Zhao, Z.-Q. Hu, S. Okubo, Y. Hara, T. Shimamura, Mechanism of Synergy between Epigallocatechin Gallate and-Lactams against Methicillin-Resistant Staphylococcus aureus. 45(6) (2001) 1737\u20131742. https:\/\/doi.org\/10.1128\/AAC.45.6.1737-1742.2001.","DOI":"10.1128\/AAC.45.6.1737-1742.2001"},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.003_b0255","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0976-0105.183265","article-title":"Antibacterial synergy of curcumin with antibiotics against biofilm producing clinical bacterial isolates","volume":"7","author":"Kali","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.ejpb.2021.02.003_b0260","doi-asserted-by":"crossref","unstructured":"M. Moshe, J. Lellouche, E. Banin, Curcumin: a natural antibiofilm agent, 2011, 89\u201393. https:\/\/doi.org\/10.1142\/9789814354868_0017.","DOI":"10.1142\/9789814354868_0017"},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.003_b0265","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ptr.5994","article-title":"Curcumin, an antibiotic resistance breaker against a multiresistant clinical isolate of Mycobacterium abscessus","volume":"32","author":"Marini","year":"2018","journal-title":"Phytother. Res."},{"issue":"8","key":"10.1016\/j.ejpb.2021.02.003_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25081986","article-title":"Interactions of tea-derived catechin gallates with bacterial pathogens","volume":"25","author":"Taylor","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ejpb.2021.02.003_b0275","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4155\/tde-2017-0118","article-title":"Nanomedicine: Is it lost in translation?","volume":"9","author":"Greish","year":"2018","journal-title":"Therapeutic Deliv."},{"issue":"11","key":"10.1016\/j.ejpb.2021.02.003_b0280","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/dmd.30.11.1246","article-title":"Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats","volume":"30","author":"Cai","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.003_b0285","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/antiox9030208","article-title":"Monoalkylated epigallocatechin-3-gallate (C18-EGCG) as novel lipophilic EGCG derivative: characterization and antioxidant evaluation","volume":"9","author":"Minnelli","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejpb.2021.02.003_b0290","doi-asserted-by":"crossref","first-page":"45521","DOI":"10.1038\/srep45521","article-title":"Preparation and characterization of (\u2212)-Epigallocatechin-3-gallate (EGCG)-loaded nanoparticles and their inhibitory effects on Human breast cancer MCF-7 cells","volume":"7","author":"Zeng","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2021.02.003_b0295","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jfoodeng.2018.09.008","article-title":"Encapsulation of (\u2500)-epigallocatechin-3-gallate (EGCG) in solid lipid nanoparticles for food applications","volume":"244","author":"Shtay","year":"2019","journal-title":"J. Food Eng."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.003_b0300","doi-asserted-by":"crossref","first-page":"326S","DOI":"10.1093\/ajcn\/81.1.326S","article-title":"Risks and safety of polyphenol consumption","volume":"81","author":"Mennen","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.003_b0305","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejpb.2021.02.003_b0310","doi-asserted-by":"crossref","unstructured":"U. Bulbake, S. Doppalapudi, N. Kommineni, W. Khan, Liposomal formulations in clinical use: an updated review, in: Pharmaceutics, vol. 9(2). MDPI AG, 2017. https:\/\/doi.\/org\/10.3390\/pharmaceutics9020012.","DOI":"10.3390\/pharmaceutics9020012"},{"issue":"11","key":"10.1016\/j.ejpb.2021.02.003_b0315","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/17425247.2019.1669558","article-title":"Lipid-based nanoparticle formulations for small molecules and RNA drugs","volume":"16","author":"Ickenstein","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"issue":"8","key":"10.1016\/j.ejpb.2021.02.003_b0320","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2217\/nnm.11.122","article-title":"Liposomes as drug delivery systems for the treatment of TB","volume":"6","author":"Pinheiro","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2021.02.003_b0325","doi-asserted-by":"crossref","unstructured":"H. Daraee, A. Etemadi, M. Kouhi, S. Alimirzalu, A. Akbarzadeh, Application of liposomes in medicine and drug delivery, in: Artificial Cells, Nanomedicine and Biotechnology, vol. 44(1). Taylor and Francis Ltd., 2016, pp. 381\u2013391. https:\/\/doi.org\/10.3109\/21691401.2014.953633.","DOI":"10.3109\/21691401.2014.953633"},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.003_b0330","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF01967536","article-title":"Liposomes in treatment of infectious diseases","volume":"9","author":"Emmen","year":"1987","journal-title":"Pharmaceutisch Weekblad Sci. Ed."},{"issue":"17","key":"10.1016\/j.ejpb.2021.02.003_b0335","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1039\/b923535n","article-title":"Liposomes as\u2019smart\u2019 pharmaceutical nanocarriers","volume":"6","author":"Sawant","year":"2010","journal-title":"Soft Matter"},{"issue":"4","key":"10.1016\/j.ejpb.2021.02.003_b0340","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal amphotericin B (AmBisome\u00ae): a review of the pharmacokinetics, pharmacodynamics clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ejpb.2021.02.003_b0345","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.colsurfb.2019.05.056","article-title":"Glucosylated liposomes as drug delivery systems of usnic acid to address bacterial infections","volume":"181","author":"Francolini","year":"2019","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejpb.2021.02.003_b0350","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejpb.2019.09.016","article-title":"Liposomes augment biological benefits of curcumin for multitargeted skin therapy","volume":"144","author":"Ternullo","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.003_b0355","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01644088","article-title":"Liposomes as drug delivery system in the treatment of infectious diseases potential applications and clinical experience","volume":"16","author":"Coune","year":"1988","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.003_b0360","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics11020053","article-title":"Localized therapy of vaginal infections and inflammation: liposomes-in-hydrogel delivery system for polyphenols","volume":"11","author":"Joraholmen","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2021.02.003_b0365","doi-asserted-by":"crossref","unstructured":"Agrahari, Vibhuti, V. Agrahari, Advances and applications of block-copolymer-based nanoformulations, in: Drug Discovery Today, vol. 23(5), Elsevier Ltd, 2018, pp. 1139\u20131151. https:\/\/doi.org\/10.1016\/j.drudis.2018.03.004.","DOI":"10.1016\/j.drudis.2018.03.004"},{"issue":"12","key":"10.1016\/j.ejpb.2021.02.003_b0370","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nature Rev. Mater."},{"key":"10.1016\/j.ejpb.2021.02.003_b0375","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jconrel.2014.04.056","article-title":"In situ gelling pH- and temperature-sensitive biodegradable block copolymer hydrogels for drug delivery","volume":"193","author":"Singh","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.02.003_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.05.031","article-title":"Thermosensitive hydrogels for sustained-release of sorafenib and selenium nanoparticles for localized synergistic chemoradiotherapy","volume":"216","author":"Zheng","year":"2019","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.ejpb.2021.02.003_b0385","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.polymer.2008.01.027","article-title":"Hydrogels in drug delivery: progress and challenges","volume":"49","author":"Hoare","year":"2008","journal-title":"Polymer"},{"key":"10.1016\/j.ejpb.2021.02.003_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119334","article-title":"Therapeutic efficacy of thermosensitive Pluronic hydrogel for codelivery of resveratrol microspheres and cisplatin in the treatment of liver cancer ascites","volume":"582","author":"Wen","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2021.02.003_b0395","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.apsb.2017.03.002","article-title":"Amino-functionalized poloxamer 407 with both mucoadhesive and thermosensitive properties: preparation, characterization and application in a vaginal drug delivery system","volume":"7","author":"Ci","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.ejpb.2021.02.003_b0400","doi-asserted-by":"crossref","DOI":"10.1002\/app.41613","article-title":"Controlled dual release study of curcumin and a 4-aminoquinoline analog from gum acacia containing hydrogels","volume":"132","author":"Aderibigbe","year":"2015","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.ejpb.2021.02.003_b0405","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.colsurfb.2015.12.033","article-title":"Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique","volume":"140","author":"Becker Peres","year":"2016","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejpb.2021.02.003_b0410","first-page":"23","article-title":"Nanoparticle drug delivery systems for \u03b1-mangostin","volume":"vol. 13","author":"Wathoni","year":"2020"},{"key":"10.1016\/j.ejpb.2021.02.003_b0415","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/750891","article-title":"Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery","volume":"2012","author":"Severino","year":"2012","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.ejpb.2021.02.003_b0420","doi-asserted-by":"crossref","unstructured":"A. zur M\u00fchlen, C. Schwarz, W. Mehnert, Solid lipid nanoparticles (SLN) for controlled drug delivery-Drug release and release mechanism, 1998.","DOI":"10.1016\/S0939-6411(97)00150-1"},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.003_b0425","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejps.2013.03.013","article-title":"Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride","volume":"49","author":"Vaghasiya","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2021.02.003_b0430","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1166\/jbn.2011.1332","article-title":"AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration","volume":"7","author":"Patel","year":"2011","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejpb.2021.02.003_b0435","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2014.06.055","article-title":"Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors","volume":"192","author":"Nafee","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.02.003_b0440","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.colsurfb.2015.03.049","article-title":"Sodium alginate-cross-linked polymyxin B sulphate-loaded solid lipid nanoparticles: antibiotic resistance tests and HaCat and NIH\/3T3 cell viability studies","volume":"129","author":"Severino","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"29","key":"10.1016\/j.ejpb.2021.02.003_b0445","doi-asserted-by":"crossref","first-page":"22665","DOI":"10.1039\/C4RA15802D","article-title":"Characterization of solid lipid nanoparticles produced with carnauba wax for rosmarinic acid oral delivery","volume":"5","author":"Madureira","year":"2015","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.003_b0450","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/mnfr.201000310","article-title":"Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin","volume":"55","author":"Kakkar","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.003_b0455","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2008.10.002","article-title":"Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles","volume":"133","author":"Li","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.02.003_b0460","first-page":"911","article-title":"Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics","volume":"10","author":"Ji","year":"2016","journal-title":"Drug Des., Develop. Therapy"},{"key":"10.1016\/j.ejpb.2021.02.003_b0465","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejpb.2021.02.003_b0470","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejpb.2019.09.002","article-title":"Challenges and strategies in drug delivery systems for treatment of pulmonary infections","volume":"144","author":"Ho","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.02.003_b0475","unstructured":"NanoHybrids - Approved Nanoparticles for Medical Use. (n.d.). Retrieved September 3, 2020, from https:\/\/nanohybrids.net\/pages\/cleared-nanoparticles-for-medical-use."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.003_b0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-9-684","article-title":"Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles","volume":"9","author":"Dian","year":"2014","journal-title":"Nanoscale Res. Lett."},{"issue":"10","key":"10.1016\/j.ejpb.2021.02.003_b0485","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3390\/molecules23102527","article-title":"Polymeric nanocarriers for the delivery of antimalarials","volume":"23","author":"Mhlwatika","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.003_b0490","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/10717544.2014.910564","article-title":"Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid","volume":"23","author":"Madaan","year":"2016","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.003_b0495","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3390\/ijms21020499","article-title":"Antimicrobial chitosan conjugates: current synthetic strategies and potential applications","volume":"21","author":"Qin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2021.02.003_b0500","doi-asserted-by":"crossref","unstructured":"H. Yilmaz Atay, Antibacterial activity of chitosan-based systems, in: Functional Chitosan. Springer Singapore, 2019, pp. 457\u2013489. https:\/\/doi.org.10.1007\/978-981-15-0263-7_15.","DOI":"10.1007\/978-981-15-0263-7_15"},{"key":"10.1016\/j.ejpb.2021.02.003_b0505","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.carbpol.2016.05.109","article-title":"Polyphenol-chitosan conjugates: Synthesis, characterization, and applications","volume":"151","author":"Hu","year":"2016","journal-title":"Carbohydrate Polym."},{"key":"10.1016\/j.ejpb.2021.02.003_b0510","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.carbpol.2014.10.026","article-title":"Mucoadhesive electrospun chitosan-based nanofibre mats for dental caries prevention","volume":"117","author":"Samprasit","year":"2015","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.003_b0515","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-040210-162544","article-title":"Nanoparticle delivery of cancer drugs","volume":"63","author":"Wang","year":"2012","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.003_b0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-54752-4","article-title":"Curcumin to promote the synthesis of Silver NPs and their self-assembly with a thermoresponsive polymer in core-shell nanohybrids","volume":"9","author":"Soto-Quintero","year":"2019","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.ejpb.2021.02.003_b0525","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1039\/D0TB00158A","article-title":"Hybrid silver-gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection","volume":"8","author":"Bhatia","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejpb.2021.02.003_b0530","unstructured":"Fda, & Cder (n.d.). AVINZA (morphine sulfate) extended-release capsules, CII.April 2014, from www.avinza.com."},{"key":"10.1016\/j.ejpb.2021.02.003_b0535","doi-asserted-by":"crossref","unstructured":"J. Della Rocca, D. Liu, W. Lin, Are high drug loading nanoparticles the next step forward for chemotherapy?, in: Nanomedicine, vol. 7(3). NIH Public Access, 2012, pp. 303\u2013305. https:\/\/doi.org\/10.2217\/nnm.11.191.","DOI":"10.2217\/nnm.11.191"},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.003_b0540","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s10570-017-1646-6","article-title":"Controlled release of carvacrol and curcumin: bio-based food packaging by synergism action of TEMPO-oxidized cellulose nanocrystals and cyclodextrin","volume":"25","author":"de Castro","year":"2018","journal-title":"Cellulose"},{"issue":"119","key":"10.1016\/j.ejpb.2021.02.003_b0545","doi-asserted-by":"crossref","first-page":"97988","DOI":"10.1039\/C5RA19699J","article-title":"Hyperlipidemia affects the absorption, distribution and excretion of seven catechins in rats following oral administration of tea polyphenols","volume":"5","author":"Xu","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2021.02.003_b0550","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejpb.2016.08.001","article-title":"Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: current evidence from in vitro and in vivo evaluation","volume":"108","author":"Doktorovov\u00e1","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.02.003_b0555","doi-asserted-by":"crossref","unstructured":"J. Deng, H. Yang, E. Capanoglu, H. Cao, J. Xiao, Technological aspects and stability of polyphenols, in: Polyphenols: Properties, Recovery, and Applications. Elsevier, 2018, pp. 295\u2013323. https:\/\/doi.org\/10.1016\/B978-0-12-813572-3.00009-9.","DOI":"10.1016\/B978-0-12-813572-3.00009-9"},{"key":"10.1016\/j.ejpb.2021.02.003_b0560","doi-asserted-by":"crossref","unstructured":"Agrahari, Vibhuti, V. Agrahari, Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities, in: Drug Discovery Today, vol. 23(5). Elsevier Ltd, 2018, pp. 974\u2013991. https:\/\/doi.org\/0.1016\/j.drudis.2018.01.047.","DOI":"10.1016\/j.drudis.2018.01.047"},{"key":"10.1016\/j.ejpb.2021.02.003_b0565","doi-asserted-by":"crossref","unstructured":"Agrahari, Vivek, P. Hiremath, Challenges associated and approaches for successful translation of nanomedicines into commercial products, in :Nanomedicine, vol. 12(8). Future Medicine Ltd., 2017, pp. 819\u2013823. https:\/\/doi.org\/10.2217\/nnm-2017-0039.","DOI":"10.2217\/nnm-2017-0039"},{"key":"10.1016\/j.ejpb.2021.02.003_b0570","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.chroma.2018.07.046","article-title":"Quality by design compliant strategy for the development of a liquid chromatography\u2013tandem mass spectrometry method for the determination of selected polyphenols in Diospyros kaki","volume":"1569","author":"Ancillotti","year":"2018","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejpb.2021.02.003_b0575","unstructured":"Apigenin | C15H10O5 - PubChem. (n.d.). Retrieved May 26, 2020, from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/5280443#section=Vapor-Pressure."},{"key":"10.1016\/j.ejpb.2021.02.003_b0580","unstructured":"Kaempferol | C15H10O6 - PubChem. (n.d.). Retrieved May 26, 2020, from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/5280863#section=Solubility."},{"key":"10.1016\/j.ejpb.2021.02.003_b0585","unstructured":"Rutin | C27H30O16 - PubChem. (n.d.). Retrieved May 26, 2020, from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/5280805."},{"key":"10.1016\/j.ejpb.2021.02.003_b0590","unstructured":"Baicalein | C15H10O5 - PubChem. (n.d.). Retrieved May 26, 2020, from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/5281605#section=Depositor-Supplied-Synonyms."},{"key":"10.1016\/j.ejpb.2021.02.003_b0595","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2018.03.006","article-title":"Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma","volume":"277","author":"Jhaveri","year":"2018","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.003_b0600","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/03639045.2012.756512","article-title":"Deformable liposomes by reverse-phase evaporation method for an enhanced skin delivery of (+)-catechin","volume":"40","author":"Chen","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"8","key":"10.1016\/j.ejpb.2021.02.003_b0605","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3109\/1061186X.2010.551402","article-title":"Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin","volume":"19","author":"Huang","year":"2011","journal-title":"J. Drug Targeting"},{"key":"10.1016\/j.ejpb.2021.02.003_b0610","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.colsurfb.2013.03.059","article-title":"Curcumin-containing liposomes stabilized by thin layers of chitosan derivatives","volume":"109","author":"Karewicz","year":"2013","journal-title":"Colloids Surf., B"},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.003_b0615","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/polym6010039","article-title":"Synthesis of gelatin-\u03b3-Polyglutamic acid-based hydrogel for the in vitro controlled release of epigallocatechin gallate (EGCG) from Camellia sinensis","volume":"6","author":"Garcia","year":"2014","journal-title":"Polymers"},{"key":"10.1016\/j.ejpb.2021.02.003_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2019.101199","article-title":"Loading of cancer drug resveratrol to pH-Sensitive, smart, alginate-chitosan hydrogels and investigation of controlled release kinetics","volume":"53","author":"Nazl\u0131","year":"2019","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"3","key":"10.1016\/j.ejpb.2021.02.003_b0625","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.msec.2011.11.018","article-title":"New cellulose-lignin hydrogels and their application in controlled release of polyphenols","volume":"32","author":"Ciolacu","year":"2012","journal-title":"Mater. Sci. Eng., C"},{"issue":"20","key":"10.1016\/j.ejpb.2021.02.003_b0630","doi-asserted-by":"crossref","first-page":"16880","DOI":"10.1021\/acsami.7b03347","article-title":"Silver-decorated polymeric micelles combined with curcumin for enhanced antibacterial activity","volume":"9","author":"Huang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.ejpb.2021.02.003_b0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-10672-9","article-title":"Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria","volume":"7","author":"Dende","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2021.02.003_b0640","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2015.06.040","article-title":"Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo","volume":"213","author":"Cote","year":"2015","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.ejpb.2021.02.003_b0645","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/nano7110379","article-title":"Increased loading, efficacy and sustained release of silibinin, a poorly soluble drug using hydrophobically-modified chitosan nanoparticles for enhanced delivery of anticancer drug delivery systems","volume":"7","author":"Kuen","year":"2017","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejpb.2021.02.003_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2019.101386","article-title":"Controlled release of curcumin from electrospun fiber mats with antibacterial activity","volume":"55","author":"Mahmud","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2021.02.003_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118947","article-title":"Controlled curcumin release from nanofibers based on amphiphilic-block segmented polyurethanes","volume":"575","author":"Shababdoust","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.003_b0660","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/09205063.2019.1680928","article-title":"Curcumin-loaded electrospun polycaprolactone\/montmorillonite nanocomposite: wound dressing application with anti-bacterial and low cell toxicity properties","volume":"31","author":"Sadeghianmaryan","year":"2020","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.ejpb.2021.02.003_b0665","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejps.2018.07.043","article-title":"Influence of controlled release of resveratrol from electrospun fibers in combination with siRNA on leukemia cells","volume":"123","author":"Al-Attar","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.02.003_b0670","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.2147\/IJN.S167670","article-title":"Mangosteen pericarp extract embedded in electrospun PVP nanofiber mats: physicochemical properties and release mechanism of \u03b1-mangostin","volume":"13","author":"Sriyanti","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2021.02.003_b0675","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.2147\/IJN.S211130","article-title":"Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity","volume":"14","author":"Zhang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2021.02.003_b0680","unstructured":"Quercetin | C15H10O7 - PubChem. (n.d.). Retrieved May 25, 2020, from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Quercetin#section=Solubility."},{"key":"10.1016\/j.ejpb.2021.02.003_b0685","unstructured":"Resveratrol | C14H12O3 - PubChem. (n.d.). Retrieved May 25, 2020, from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Resveratrol#section=Other-Experimental-Properties."},{"key":"10.1016\/j.ejpb.2021.02.003_b0690","unstructured":"Naringenin | C15H12O5 - PubChem. (n.d.). Retrieved May 26, 2020, from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/932."},{"key":"10.1016\/j.ejpb.2021.02.003_b0695","unstructured":"Naringenin - DrugBank. (n.d.). Retrieved May 26, 2020, from https:\/\/www.drugbank.ca\/drugs\/DB03467."},{"key":"10.1016\/j.ejpb.2021.02.003_b0700","unstructured":"Causes of Antimicrobial (Drug) Resistance | NIH: National Institute of Allergy and Infectious Diseases. (n.d.). Retrieved May 14, 2020, from https:\/\/www.niaid.nih.gov\/research\/antimicrobial-resistance-causes."},{"key":"10.1016\/j.ejpb.2021.02.003_b0705","unstructured":"Cianidanol | C15H14O6 - PubChem. (n.d.). Retrieved May 25, 2020, from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9064#section=Hepatotoxicity."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.003_b0710","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/0748233713498458","article-title":"Antibacterial effects of curcumin: an in vitro minimum inhibitory concentration study","volume":"32","author":"Gunes","year":"2016","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.ejpb.2021.02.003_b0715","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejpb.2016.08.011","article-title":"Quercetin topical application, from conventional dosage forms to nanodosage forms","volume":"108","author":"Hatahet","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"8","key":"10.1016\/j.ejpb.2021.02.003_b0720","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1055\/s-2008-1074559","article-title":"The effects of antibiotics combined with natural polyphenols against clinical methicillin-resistant Staphylococcus aureus (MRSA)","volume":"74","author":"Lin","year":"2008","journal-title":"Planta Med."},{"issue":"4","key":"10.1016\/j.ejpb.2021.02.003_b0725","article-title":"Resveratrol antagonizes antimicrobial lethality and stimulates recovery of bacterial mutants","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.003_b0730","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1023\/A:1016051316815","article-title":"Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs","volume":"13","author":"Merisko-Liversidge","year":"1996","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.ejpb.2021.02.003_b0735","doi-asserted-by":"crossref","first-page":"20091","DOI":"10.3390\/molecules191220091","article-title":"The chemistry of curcumin: From extraction to therapeutic agent","volume":"19","author":"Priyadarsini","year":"2014","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.ejpb.2021.02.003_b0740","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1021\/jf0483669","article-title":"Experimental determination of octanol-water partition coefficients of quercetin and related flavonoids","volume":"53","author":"Rothwell","year":"2005","journal-title":"J. Agric. Food. Chem."},{"issue":"2","key":"10.1016\/j.ejpb.2021.02.003_b0745","doi-asserted-by":"crossref","first-page":"N494","DOI":"10.1111\/1750-3841.13208","article-title":"Enhancement of curcumin solubility by phase change from crystalline to amorphous in Cur-TPGS nanosuspension","volume":"81","author":"Shin","year":"2016","journal-title":"J. Food Sci."},{"issue":"9","key":"10.1016\/j.ejpb.2021.02.003_b0750","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1021\/je901097n","article-title":"Solubility of gallic acid, catechin, and protocatechuic acid in subcritical water from (298.75 to 415.85) K","volume":"55","author":"Srinivas","year":"2010","journal-title":"J. Chem. Eng. Data"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2021.02.003_b0755","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ijpharm.2017.06.068","article-title":"Enhancement of solubility and dissolution rate of baicalein, wogonin and oroxylin A extracted from Radix scutellariae","volume":"528","author":"Yu","year":"2017","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:41:41Z","timestamp":1760546501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121000412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":151,"alternative-id":["S0939641121000412"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.02.003","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyphenols against infectious diseases: Controlled release nano-formulations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}